UK Accelerator Institutes Seminar Series Autumn 2024 (Session 11)

Contribution List

1. LCLS-II Commissioning Results and Lessons Learned

Nicole Neveu (Argonne National Laboratory)

22/10/2024, 15:30

PLEASE NOTE THE UNUSUAL DAY AND TIME OF THIS TALK. IT WILL TAKE PLACE IN THE MERRISON LECTURE THEATRE AT DARESBURY LABORATORY AND ALSO BE BROADCAST VIA ZOOM.

In this talk, I will present the initial LCLS-II commissioning results and some lessons learned along the way. The injector and all 35 cryomodules have been operating stably for over a year up to 3.5 GeV. Starting this month (October...

2. The CERN Linear Accelerator for Research (CLEAR) User Facility at CERN: Status and Highlights of the Experimental Programme.

Roberto Corsini (CERN)

24/10/2024, 16:15

The CERN Linear Accelerator for Research (CLEAR) is composed of a versatile 200 MeV electron linac followed by a 20 m experimental beamline, and is operated as a multi-purpose user facility at CERN. Running in parallel with the main CERN accelerator complex, but completely independent from it, CLEAR started operation in 2017 and has been providing electron beams to a large and varied range of...

3. PARticle Therapy REsearch Center (PARTREC): From Nuclear Physics to Medicine

Alexander Gerbershagen (PARTREC, UMCG, University of Groningen (NL))

07/11/2024, 16:15

After 25 years of successful research in the nuclear and radiation physics domain, the KVI-CART research center in Groningen has been upgraded and re-established as the PARticle Therapy REsearch Center (PARTREC). Using the superconducting cyclotron AGOR and being embedded within the University Medical Center Groningen, it operates in close collaboration with the Groningen Proton Therapy...

5. Lasers for Accelerators and Recent Technology Development

Marta Divall (Paul Scherrer Institute)

14/11/2024, 16:15

7. CERN-MEDICIS: Experience of Mass-Separation with Radionuclides towards their Clinical Translation

Thierry Stora (CERN)

28/11/2024, 16:15

CERN-MEDICIS produces radionuclides by mass separation for biomedical research. The facility exploits targets either irradiated with PS Booster high-energy proton beam or irradiated at cyclotrons and in research nuclear reactors at partner institutes that are part of the MEDICIS Collaboration.The facility extends isotope mass separation techniques towards the reliable and efficient production...

8. Seminar